We are honored to share highlights from the Emory Percutaneous Intervention Course (EPIC 26), featuring Prof Bernardo Cortese’s presentation and insights on the latest clinical evolutions of DCB technology, specifically the Virtue Sirolimus AngioInfusion Balloon (SAB).
We are entering a new era of local drug delivery that evolves beyond traditional surface coatings. By utilizing protected internal infusion, we can achieve targeted drug uptake with minimal ‘transit loss’ and an enhanced safety profile. The robust angiographic and QCA outcomes shared today confirm that the future of vascular restoration lies in this high-precision, internal delivery model.
A huge thank you to the Emory team for hosting such a vital scientific dialogue. The momentum in interventional innovation has never been stronger!
1st Asia-Pacific Stentless PCI Course in Chennai